Christopher P. Stewart

Christopher P. Stewart is a declared insider at 2 companies (finance chief); the most frequent names are Bionano Genomics, Inc. and Aeluma, Inc. We count 10 filings; the first trade dates from 22 January 2021 and the latest from 30 September 2026.

Every open-market trade on record is a purchase: 1 purchase worth €31k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 6 share grants and 3 option exercises.

The latest filing, published on 1 October 2026, reports a share grant of €62k in Aeluma, Inc. The last insider purchase was made public on 16 May 2023, 1,258 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.